News & Articles

The blood-based immunoassay test enables clinicians to identify the virus linked with COVID-19

The serology test promises 100% sensitivity and can help assess patients' immune response to the virus

The antibody test, which has a potential time to result of 14 minutes, will join the rest of the company's diagnostic portfolio

The company aims to provide solutions for the pandemic through close collaboration with scientists and providing cutting-edge laboratory equipment

Learn more about how BINDER is helping countless laboratories across the world conduct research into coronavirus.

Collaboration will enable global development, manufacturing and distribution of the vaccine

These models aim to accelerate treatment development prior to clinical trials

The test will be available for qualified laboratories across the European Union by the end of May

Leinco Technologies will co-develop a rapid, point of care, immunodiagnostic test for the detection of the SARS-CoV-2 virus responsible for COVID-19

Visitors to the virtual event can also experience continuous production from powders to the finished capsule with the specially developed X-key principle

Following regulatory approval, the first clinical trial of the coronavirus vaccine candidates is said to commence in late April

Pioneering new class of diagnostic product will transform fight against pandemic

Watch this on-demand webinar to understand how better research diagnostic methods can lead to improved treatment of congenital metabolopathies

The combination of the unique technologies aims to bring a novel angle to combat the global pandemic

Explore a compilation of some of the most innovative technology news relating to the novel coronavirus and the COVID-19 disease

The team at the University of Edinburgh believe new therapies could be discovered before a vaccine becomes available

The new product line includes the MutaPLEX RT-PCR assay and ELISA kits to detect IgM and IgG antibodies

The IgA, IgG, and IgM assays are formatted for optimal functionality in diagnostic laboratories

The testing capability of Mologic's kits is expected to relieve immediate testing pressures in the UK and Africa

The detection of these antibodies could help indicate if a person has gained immunity against the virus and inform treatment decisions

The only FDA-approved test that measures G6PD provides key insight to inform drug therapy options

The serology immunoassay kit aims to help clinicians diagnose the coronavirus by analyzing the immune response against SARS-CoV-2

The strategic partnership with Australian National Phenome Centre (ANPC) aims to support the work of their researchers

Vehicle manufacturer utilizes infrastructure to expand production to face masks and gowns for frontline medical staff